Evidence map›Paper›PMID 40123413›Full record

ArticleEpidemiology and infection2025

Quantifying the direct and indirect components of COVID-19 vaccine effectiveness during the Delta variant era.

Anna Suomenrinne-Nordvik, Tuija Leino, Mikhail Shubin, Kari Auranen, Simopekka Vänskä

Erratum issuedAbstract read
In one paragraph

Article in Epidemiology and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Anna Suomenrinne-NordvikDepartment of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0001-7678-6554
Tuija LeinoDepartment of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.
Mikhail ShubinDepartment of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.
Kari AuranenDepartment of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.
Simopekka VänskäDepartment of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0002-5677-721X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of COVID-19 vaccines against the Delta variant has been observed to be high, both against severe disease and infection. The full population level vaccine effectiveness, however, also contains the indirect effects of vaccination, which require analysis of transmission dynamics to uncover. Finland was close to naïve to SARS-CoV-2 infections before the Delta dominant era, and non-pharmaceutical interventions (NPIs) were at an internationally low level. We utilize Finnish register data and a mathematical model for transmission and COVID-19 disease burden to construct a completely unvaccinated control population and estimate the different components of the vaccine effectiveness. The estimated direct effectiveness was 72% against COVID-19 cases and 87-96% against severe disease outcomes, but the estimated indirect effectiveness was even better, 93% against cases and 94-97% against severe disease. The total and overall effectiveness, including both direct and indirect effects of vaccination, were thus excellent. Our results show how well the population was protected by vaccination during the Delta era, especially by the indirect effectiveness, providing protection also to the unvaccinated part of the population. The estimated averted numbers of hospitalizations, ICU admissions, and deaths in Finland during the Delta era under the implemented NPIs were about 100 times the observed numbers.

Indexed as

COVID-19COVID-19 VaccinesSARS-CoV-2Vaccine EfficacyAdultAgedFemaleFinlandHospitalizationHumansMaleMiddle AgedModels, TheoreticalVaccinationYoung AdultCOVID-19 VaccinesCOVID-19Mathematical modellingVaccines

Identifiers

PMID40123413
PMCPMC12001148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.